Live lean and CRISPR – Engineering metabolism with FGF21 and FNDC5

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	e230
Journal	Clinical and Translational Discovery
Volume	3
Issue number	5
DOIs	https://doi.org/10.1002/ctd2.230
State	Published - Oct 2023
Externally published	Yes

Access to Document

@article{3c85816d7ad2490e8445a137eed3feab,

title = "Live lean and CRISPR – Engineering metabolism with FGF21 and FNDC5",

author = "{Mena G{\'o}mez}, Alba and Alexander Bartelt",

year = "2023",

month = oct,

doi = "10.1002/ctd2.230",

language = "English",

volume = "3",

journal = "Clinical and Translational Discovery",

issn = "2768-0622",

publisher = "John Wiley and Sons Inc",

number = "5",

}

TY - JOUR

T1 - Live lean and CRISPR – Engineering metabolism with FGF21 and FNDC5

AU - Mena Gómez, Alba

AU - Bartelt, Alexander

PY - 2023/10

Y1 - 2023/10

UR - http://www.scopus.com/inward/record.url?scp=85169786608&partnerID=8YFLogxK

U2 - 10.1002/ctd2.230

DO - 10.1002/ctd2.230

M3 - Comment/debate

AN - SCOPUS:85169786608

SN - 2768-0622

VL - 3

JO - Clinical and Translational Discovery

JF - Clinical and Translational Discovery

IS - 5

M1 - e230

ER -